XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2024168-2012-07985
- Event Type
- Death
- Date Received
- December 16, 2012
- Date of Event
- November 26, 2012
- Report Date
- November 26, 2012
- Manufacturer
- AV-TEMECULA-CT
- Product Code
- NIQ
- PMA / PMN Number
- P110019
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
(B)(4). THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED DEATH, HYPOTENSION AND PERFORATION ARE LISTED IN THE XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM INSTRUCTIONS FOR USE (IFU) AS A KNOWN ADVERSE EVENT ASSOCIATED WITH CORONARY STENTING. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURING, DESIGN OR LABELING AND THE TREATMENT APPEARS TO BE RELATED TO THE OPERATIONAL CONTEXT OF THE PROCEDURE.
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION LOCATED IN THE MID LEFT ANTERIOR DESCENDING ARTERY. PREDILATATION WAS PERFORMED PRIOR TO STENTING WITH A NON-ABBOTT BALLOON. A 2.5X28 MM XIENCE PRIME STENT WAS DEPLOYED SUCCESSFULLY IN THE LESION AND POST-DILATATION WAS PERFORMED WITH A NON-ABBOTT BALLOON. ON ANGIOGRAPHY THE VESSEL APPEARED OPEN; HOWEVER, HAZINESS WAS OBSERVED IN THE PROXIMAL END OF THE STENT, BUT BLOOD FLOW WAS SMOOTH. A PERFORATION WAS SUSPECTED AND THE PATIENT BEGAN EXPERIENCING A RAPID FALL OF BLOOD PRESSURE, SHORTNESS OF BREATH, AND CARDIAC ARREST. ATROPINE WAS ADMINISTERED AND PERICARDIOCENTESIS WAS PERFORMED; HOWEVER, WITH NO IMPROVEMENT AND THE PATIENT DIED WITHIN THE NEXT 30 MINUTES. NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM | DRUG ELUTING CORONARY STENT SYSTEM | NIQ | AV-TEMECULA-CT | 1081641 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 63 YR | Death |